[go: up one dir, main page]

BRPI0516453A - derivados de benzoimidazol úteis como agentes antiproliferativos - Google Patents

derivados de benzoimidazol úteis como agentes antiproliferativos

Info

Publication number
BRPI0516453A
BRPI0516453A BRPI0516453-2A BRPI0516453A BRPI0516453A BR PI0516453 A BRPI0516453 A BR PI0516453A BR PI0516453 A BRPI0516453 A BR PI0516453A BR PI0516453 A BRPI0516453 A BR PI0516453A
Authority
BR
Brazil
Prior art keywords
derivatives useful
antiproliferative agents
benzoimidazole derivatives
formula
compounds
Prior art date
Application number
BRPI0516453-2A
Other languages
English (en)
Inventor
Kirk Russell Henne
John Charles Kath
Ruby Anthea Szewc
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0516453A publication Critical patent/BRPI0516453A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

DERIVADOS de BENZOIMIDAZOL úTEIS COMO AGENTES ANTIPROLIFERATIVOS. A invenção se refere a compostos substancialmente puros da fórmula (1) e a sais farmaceuticamente aceitáveis pró-drogas e solvatos destes, em que R, R¹, R² , R³ , R¬ 4¬ , e R¬ 5¬ são como definidos aqui. A invenção da mesma forma se refere à composições farmacêuticas compreendendo os compostos da fórmula (1) e métodos de tratar crescimento celular anormal, tal como câncer, em mamíferos administrando-se tais formulações farmacêuticas.
BRPI0516453-2A 2004-10-07 2005-10-03 derivados de benzoimidazol úteis como agentes antiproliferativos BRPI0516453A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61697804P 2004-10-07 2004-10-07
PCT/IB2005/003034 WO2006038111A1 (en) 2004-10-07 2005-10-03 Benzoimidazole derivatives useful as antiproliferative agents

Publications (1)

Publication Number Publication Date
BRPI0516453A true BRPI0516453A (pt) 2008-09-02

Family

ID=35520072

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516453-2A BRPI0516453A (pt) 2004-10-07 2005-10-03 derivados de benzoimidazol úteis como agentes antiproliferativos

Country Status (7)

Country Link
US (1) US20100016353A1 (pt)
EP (1) EP1799670A1 (pt)
JP (1) JP2008515872A (pt)
BR (1) BRPI0516453A (pt)
CA (1) CA2582479C (pt)
MX (1) MX2007004183A (pt)
WO (1) WO2006038111A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8055711B2 (en) * 2004-10-29 2011-11-08 Emc Corporation Non-blocking commit protocol systems and methods
US8051425B2 (en) * 2004-10-29 2011-11-01 Emc Corporation Distributed system with asynchronous execution systems and methods
US7551572B2 (en) * 2005-10-21 2009-06-23 Isilon Systems, Inc. Systems and methods for providing variable protection
US7917474B2 (en) * 2005-10-21 2011-03-29 Isilon Systems, Inc. Systems and methods for accessing and updating distributed data
US7756898B2 (en) * 2006-03-31 2010-07-13 Isilon Systems, Inc. Systems and methods for notifying listeners of events
FR2901135B1 (fr) * 2006-05-22 2017-12-08 Oreal Utilisation de modulateurs de la glycolyse comme agents diminuant la proliferation des keratinocytes
US7590652B2 (en) * 2006-08-18 2009-09-15 Isilon Systems, Inc. Systems and methods of reverse lookup
US7822932B2 (en) * 2006-08-18 2010-10-26 Isilon Systems, Inc. Systems and methods for providing nonlinear journaling
US7899800B2 (en) * 2006-08-18 2011-03-01 Isilon Systems, Inc. Systems and methods for providing nonlinear journaling
US7680836B2 (en) * 2006-08-18 2010-03-16 Isilon Systems, Inc. Systems and methods for a snapshot of data
US8286029B2 (en) 2006-12-21 2012-10-09 Emc Corporation Systems and methods for managing unavailable storage devices
US20080155191A1 (en) * 2006-12-21 2008-06-26 Anderson Robert J Systems and methods for providing heterogeneous storage systems
WO2008124323A1 (en) 2007-04-03 2008-10-16 Array Biopharma Inc. Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
US7779048B2 (en) 2007-04-13 2010-08-17 Isilon Systems, Inc. Systems and methods of providing possible value ranges
US7966289B2 (en) * 2007-08-21 2011-06-21 Emc Corporation Systems and methods for reading objects in a file system
HU230981B1 (hu) * 2007-10-12 2019-08-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Eljárás rosuvastatin só előállítására
HU230637B1 (hu) * 2007-10-12 2017-05-29 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Eljárás rosuvastatin intermedierek előállítására
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
NZ605889A (en) * 2010-06-24 2014-10-31 Takeda Pharmaceutical Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
TWI570122B (zh) * 2011-06-22 2017-02-11 武田藥品工業股份有限公司 稠合雜環化合物之結晶
EP2906040B1 (en) * 2012-08-22 2021-02-17 Merck Sharp & Dohme Corp. Novel benzimidazole tetrahydropyran derivatives
TWI569799B (zh) * 2012-09-21 2017-02-11 安羅格製藥股份有限公司 抑制組成型活性磷酸化ｆｌｔ３激酶的方法
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
CN114981298B (zh) 2019-12-12 2024-08-20 听治疗有限责任公司 用于预防和治疗听力损失的组合物和方法
JP2023536920A (ja) * 2020-08-05 2023-08-30 ザ ジェネラル ホスピタル コーポレイション 塩誘導性キナーゼ阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75055C2 (uk) * 1999-11-30 2006-03-15 Пфайзер Продактс Інк. Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
PA8580301A1 (es) * 2002-08-28 2005-05-24 Pfizer Prod Inc Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos
CL2004001470A1 (es) * 2003-06-24 2005-05-13 Pfizer Prod Inc Procedimiento de preparacion de derivados de [(benzoimidazol-1-il)-quinolin-8-il]-piperidin-4-ilamina, utiles en el tratamiento del crecimiento celular anormal, por desproteccion del grupo boc con un alcoxido de metal en presencia de un equivalente d

Also Published As

Publication number Publication date
MX2007004183A (es) 2007-06-07
CA2582479C (en) 2011-07-12
JP2008515872A (ja) 2008-05-15
WO2006038111A1 (en) 2006-04-13
EP1799670A1 (en) 2007-06-27
CA2582479A1 (en) 2006-04-13
US20100016353A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
BRPI0516453A (pt) derivados de benzoimidazol úteis como agentes antiproliferativos
BR0313942A (pt) Derivados de benzimidazol úteis como agentes antiproliferativos
BR0317435A (pt) Derivados de pirimidina para o tratamento do crescimento celular anormal
MY148636A (en) Benzimidazole derivatives
CY1118915T1 (el) Αντιβακτηριακα αναλογα αμινογλυκοσιδης
BR0008202A (pt) Derivados de quinolin-2-ona substituìdos com heteroarilas úteis como agentes contra o câncer
BR0210507A (pt) Azaindóis
BRPI0413152A (pt) derivados de benzimidazol alquilado por n3 como inibidores de mek
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
ECSP055867A (es) Derivados de pirrolopirimidina
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
CO6470846A2 (es) Derivados aminobut´ricos sustituidos como inhibidores de neprilisina
NO20081554L (no) Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav
NO20064077L (no) Kemokinreseptorantagonister
EA200701780A1 (ru) Противоопухолевое средство
BRPI0409230A (pt) formas de dosagem compreendendo ag013736
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20084543L (no) Benzimidazolderivater
UY27980A1 (es) Indoles 2,7-sustituidos
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
BR0317433A (pt) Derivados bicìclicos para o tratamento do crescimento celular anormal
WO2004066952A3 (en) Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
JP2009520813A5 (pt)
TW200635592A (en) Pyridyl-substituted spiro-hydantoin compounds and use thereof
NO20090741L (no) Imino-imidazo-pyridinderivater med antitrombotisk aktivitet

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.